Abstract:Heart failure (HF) is a globally prevalent cardiovascular disease, but effective drug targets and diagnostic models are still lacking. This study was designed to investigate effective drug targets and diagnostic models for HF in terms of miRNA targets, hoping to contribute to the understanding and treatment of HF. Using HF miRNA and gene expression profile data from the GEO database, we analyzed differentially expressed miRNAs/gene identification in HF using Limma and predicted miRNA targets by the online TargetScan database. Subsequently, gene set enrichment analysis and annotation were performed using WebGestaltR package. Protein-protein interactions were identified using the STRING database. The proximity of drugs to treat HF was also calculated and predicted for potential target therapeutic drug. In addition, further drug identification was performed by molecular docking. Finally, diagnostic models were constructed based on differential miRNAs. The GEO dataset was used to screen 66 differentially expressed miRNAs, incorporating 56 downregulated miRNAs and 10 upregulated miRNAs. The JAK-STAT signaling pathway, MAPK signaling pathway, p53 signaling pathway, Prolactin signaling pathway, and TGF-beta signaling pathway were enriched, as shown by KEGG enrichment analysis on the target genes. In addition, we found that 83 genes were upregulated and 92 genes were downregulated in HF patients vs. healthy individuals. Based on the inflammation-related score, hypoxia-related score, and energy metabolism-related score, we identified key miRNA-mRNA pairs and constructed an interaction network. Following that, TAP1, which had the highest expression and network connectivity in acute HF with crystal and molecular docking studies, was selected as a key candidate gene in the network. And the compound DB04847 was selected to produce a large number of favorable interactions with TAP1 protein. Finally, we constructed two diagnostic models based on the differential miRNAs hsa-miR-6785-5p and hsa-miR-4443. In conclusion, we identified TAP1, a key candidate gene in the diagnosis and treatment of HF, and determined that compound DB04847 is highly likely to be a potential inhibitor of TAP1. The TAP1 gene was also found to be regulated by hsa-miR-6785-5p and hsa-miR-4443, and a diagnostic model was constructed. This provides a new promising direction to improve the diagnosis, prognosis, and treatment outcome and guide more effective immunotherapy strategies of HF.

The Application of Dynamic Models to the Exploration of Β1-Ar Overactivation As a Cause of Heart Failure

Modeling the Mechanism of [na+]i Elevation in Heart Failure by a Canine Ventricular Cell Model

Electrical Remolding And Mechanical Changes In Heart Failure: A Model Study

Theoretical Investigation Of The Mechanism Of Heart Failure Using A Canine Ventricular Cell Model: Especially The Role Of Up-Regulated Camkii And Sr Ca2+ Leak

Modelling the Integrated Regulation Role of Β-Adrenergic Signaling and CaMKII in Human Myocyte Electrophysiological Properties

Simulation of the Effect of Rogue Ryanodine Receptors on a Calcium Wave in Ventricular Myocytes with Heart Failure.

Fast Parameters Estimation in Medication Efficacy Assessment Model for Heart Failure Treatment

Mining Potential Drug Targets and Constructing Diagnostic Models for Heart Failure Based on Mirna-Mrna Networks

Biased Activation of Β2-Ar/gi/grk2 Signal Pathway Attenuated Β1-Ar Sustained Activation Induced by Β1-Adrenergic Receptor Autoantibody

Abstract 13438: The Role and Mechanism of Chronic Beta3-Adrenergic Receptor Blockade on the Progression of Heart Failure in a Rat Model

The beta-adrenergic receptor kinase in heart failure

Effect in Myocytes From Failing Rat Hearts

Distinct Actions of Intermittent and Sustained Β-Adrenoceptor Stimulation on Cardiac Remodeling

Effect of Heart Failure-Induced Electrical Remodeling on the Initiation of Atrial Arrhythmias

Bisoprolol Reversed Small Conductance Calcium-Activated Potassium Channel (sk) Remodeling in A Volume-Overload Rat Model

Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness

Emerging Concepts and Therapeutic Implications of Β-Adrenergic Receptor Subtype Signaling

Abstract 10477: Adverse Functional Significance of Cardiac Beta3-Adrenergic Receptor Activation on Left Ventricular Contractile Performance in Conscious, Chronically-Instrumented Dogs With Pacing-Induced Heart Failure

Computational modeling of Takotsubo cardiomyopathy: effect of spatially varying β-adrenergic stimulation in the rat left ventricle

Abstract 274: Spatiotemporal Regulation of Β Adrenergic Signaling in Heart Failure

Effects of Different Exercise Intensities on the Rat Model of Heart Failure